Share This Post with Your Network

Rayca Precision and CloudLIMS Bring AI-Powered Genomics Data Analysis Solutions to the Market with a Transformative Alliance

Together, Rayca Precision and CloudLIMS co-empower clinical laboratories with an integrated ecosystem that combines state-of-the-art LIMS capabilities with advanced bioinformatics analysis. By seamlessly integrating CloudLIMS’ robust laboratory management platform with Rayca Precision’s sophisticated bioinformatics solutions, laboratories can access an end-to-end data solution that streamlines operations, accelerates scientific discovery, and delivers personalized patient care. This strategic alliance promises to deliver unprecedented efficiency, innovation, and scientific discovery in healthcare.

Wilmington, DE, and London, United Kingdom – April 2, 2024, Rayca Precision, a leading exponent in bioinformatics solutions, and CloudLIMS, a leading SOC 2 compliant and ISO 9001:2015 certified lab informatics provider, announce a transformative collaboration poised to redefine the landscape of clinical laboratory operations worldwide. This synergistic alliance merges Rayca Precision’s pioneering bioinformatics expertise with CloudLIMS’ cutting-edge Laboratory Information Management System (LIMS), offering clinical laboratories an end-to-end data solution for unparalleled efficiency and scientific discovery.

Rayca Precision’s suite of bioinformatics solutions represents the pinnacle of scientific innovation, providing clinical laboratories with advanced tools to analyze and interpret genomics data with unmatched accuracy and efficiency. Rayca Precision’s solutions cover a wide spectrum of analyses, ranging from bulk to single-cell RNA-Seq, whole-genome sequencing, and proteomics. These solutions empower laboratories to efficiently extract valuable insights from complex biomedical datasets in an automated, end-to-end process. Leveraging automated machine learning algorithms, Rayca empowers laboratories to drive biomarker and target discovery, genotype-phenotype prediction, treatment response prediction, and survival analysis, as well as cohort stratification and optimization in clinical trials, revolutionizing the landscape of precision medicine and drug discovery.

RSA2 — Rayca Precision platform to analyze and interpret transcriptomic and genomics sequencing data

Complementing Rayca Precision’s bioinformatics prowess, CloudLIMS offers a comprehensive, secure, next-generation, cloud-based LIMS solution designed to automate laboratory operations and ensure regulatory compliance, such as HIPAA, ICH-GCP, GDPR, regional guidelines, and more. CloudLIMS, a quick-to-deploy, truly configurable, in-the-cloud LIMS, helps clinical labs manage samples through their complete life cycle, maintains complete traceability, and assists in managing complex laboratory operations with ease. Not only this, it facilitates collaborative studies, participant recruitment for trials, custom report generation, and inventory management. With seamless instrument and software integration capabilities, CloudLIMS empowers laboratories to centrally manage their data with precision and efficiency, eliminating data silos and ensuring seamless collaboration. The integrated solution empowers laboratories to harness the data stored in CloudLIMS for seamless downstream clinical genomics data analysis. This synergy aims to accelerate data-driven research, leading to advancements in healthcare and improved patient outcomes. Furthermore, by integrating advanced bioinformatics and genomics platforms with cutting-edge LIMS technology, this collaboration streamlines operations and enables more efficient clinical genomics data processing protocols with faster turnaround time and increased reliability.

CloudLIMS' Clinical Lab Management Software & Rayca Precision Partner to Transform Genomics Data Analysis
Figure 1: Seamlessly manage clinical studies with CloudLIMS and associate them with participants.

“Our partnership with CloudLIMS marks a pivotal moment in our mission to empower clinical laboratories with advanced bioinformatics and AI-powered genomics platforms,” stated Pouya Behrouzi, CEO of Rayca Precision. “By combining our expertise in computational biology with CloudLIMS’ industry-leading LIMS platform, we are revolutionizing the way laboratories manage and interpret clinical and genomics data, transforming patient care and driving innovation in developing new therapeutics.”

CloudLIMS echoes this sentiment, expressing excitement about the partnership’s potential to reshape the future of laboratory informatics. “Through our collaboration with Rayca Precision, we are excited to offer clinical laboratories a powerful combination of state-of-the-art laboratory management technology and cutting-edge, AI-powered bioinformatics solutions,” said Arun Apte, CEO of CloudLIMS. “The solution equips laboratories with the capability to seamlessly perform downstream clinical and genomics data analysis. This flexibility ensures that laboratories have the tools they need to adapt and excel in an ever-evolving landscape of clinical research, drug discovery, cancer research, and precision medicine.

This strategic partnership represents a significant milestone in the evolution of clinical laboratory operations. Through this collaboration, Rayca Precision and CloudLIMS reaffirm their commitment to driving scientific innovation by equipping laboratories with state-of-the-art tools and advancing patient care.

About Rayca Precision:

Rayca Precision stands as a pioneering force in the realm of bioinformatics, offering cutting-edge solutions that enable the analysis and interpretation of complex genomics and clinical data with unparalleled precision and efficiency. Leveraging sophisticated algorithms and machine learning techniques, Rayca Precision’s bioinformatics suite empowers clinical laboratories to tackle a wide array of biomedical data types, from bulk to single-cell RNA-Seq, whole-genome sequencing, and proteomics analysis. By providing advanced tools for biomarker and target discovery, genotype-phenotype prediction, survival analysis, and cohort stratification, Rayca Precision facilitates transformative insights and accelerates the pace of precision medicine and drug discovery.

Media Contact: media[at]raycabio.com

About CloudLIMS:

CloudLIMS.com offers a secure, in-the-cloud SaaS LIMS with zero upfront cost purpose-built for clinical labs and biobanks. CloudLIMS offers a wide range of complimentary services, including technical support and training, instrument integration, automatic product upgrades, legacy data migration, product configuration, automatic data back-ups, and secure data access. CloudLIMS helps clinical labs and biobanks maintain user access for PHI control, manage samples and metadata, automate and streamline workflows, meet compliance, and follow best practices such as CLIA, ISO 15189, ISO 20387:2018, EU GDPR, HIPAA, 21 CFR Part 11, and ISBER Best Practices. CloudLIMS.com is a SOC 2 Type 2 compliant and ISO 9001:2015 certified informatics company.

CloudLIMS Contact:
Mrinal Kanti Chatterjee
CloudLIMS.com
302-789-0447
support[at]cloudlims.com

Share This Post

More To Explore

The-Promise-and-Pitfalls-of-AI-in-Oncology-Separating-Fact-from-Fiction
Blogs

The Promise and Pitfalls of AI in Oncology: Separating Fact from Fiction

It is important to separate fact from fiction when it comes to the capabilities and limitations of AI in oncology and to engage in ongoing dialogue about its ethical considerations. The Promise and Pitfalls of AI in Oncology: Separating Fact from Fiction is a valuable resource for understanding the potential and limitations of AI in the field of oncology.